Optimal use determination test of GCAP(Granulocyte and Monocyte Adsorption Apheresis):Adacolumn Study on twice a week Adacolumn that target pustular psoriasis

Optimal use determination test of GCAP(Granulocyte and Monocyte Adsorption Apheresis):Adacolumn Study on twice a week Adacolumn that target pustular psoriasis - Study on twice a week GCAP that target pustular psoriasis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009775

Enrollment

Registered

2013-01-20

Start date

2012-12-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pustular psoriasis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: With the moderate to severe diseases pustular psoriasis 1 - The case in which the conventional cure does not succeed 2 The case which cannot use conventional treatments according to side effects etc. 3 The case considered that early remission introduction is required critical 4 Blood vessel requisite for extracorporeal circulation treatment is securable. 5 Who understands an explanatory matter and approval in document is made

Exclusion criteria

Exclusion criteria: 1)The patient whose granulocyte count is not more than 2,000/mm3. 2)The patient who owns a critical cardiovascular diseases 3)The hypotensive patient of 80 or less mmHg of blood-pressure systolics 4)The patient permitted extreme drying, rise of a solidification system on the strength, critical anemia, and the number fall of blood platelets 5)The patient to whom the advanced or critical adverse experience has appeared by extracorporeal circulation treatment performed in the past 6)The patient whom the physician judged to be unfit as a subject

Design outcomes

Primary

Measure	Time frame
Scoring of pustular psoriasis severe INDEX. erythema,pustule,edema,general status(fever,WBC,CRP,serum albmine)	—

Countries

Japan

Contacts

Public ContactSakiko Ohgiya

Juntendo university hospital Department of dermatology

sakigiy@juntendo.ac.jp03-3813-3111

Outcome results